Pain profile and adverse events in the control and intervention groups
| Water (N=20) | Sucrose (N=20) | p Value | |
|---|---|---|---|
| Baseline heart rate, median (range) | 154 (138–174) | 157 (134–174) | 0.89 |
| Baseline saturation, median (range) | 96 (86–99) | 96 (83–100) | 0.87 |
| N-PASS score at insertion, median (range) | 6.5 (5–11) | 5 (1–8) | 0.02 |
| N-PASS score during examination, median (range) | 9.5 (6–10) | 7.5 (2–9) | 0.03 |
| Number of patients with bradycardia | 3 | 1 | 0.328 |
| Number of patients with desaturations <80% | 3 | 1 | 0.328 |
| Number of patients with adverse events (desaturation or bradycardia) | 4 | 1 | 0.18 |
| Duration of first eye examination, mean (range) | 81.6 s (60–112) | 72.3 s (50–105) | 0.2 |
N-PASS, Neonatal Pain, Agitation and Sedation Scale.